Avidity Partners Management LP bought a new position in shares of Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 29,800 shares of the medical equipment provider’s stock, valued at approximately $2,337,000. Avidity Partners Management LP owned approximately 0.09% of Integer as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Salomon & Ludwin LLC lifted its position in shares of Integer by 46.8% during the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 118 shares in the last quarter. TD Private Client Wealth LLC lifted its position in shares of Integer by 1,037.5% during the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 415 shares in the last quarter. Parkside Financial Bank & Trust lifted its position in shares of Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 267 shares in the last quarter. Farther Finance Advisors LLC lifted its position in shares of Integer by 193.2% during the 4th quarter. Farther Finance Advisors LLC now owns 519 shares of the medical equipment provider’s stock worth $41,000 after buying an additional 342 shares in the last quarter. Finally, Huntington National Bank lifted its position in shares of Integer by 101.5% during the 4th quarter. Huntington National Bank now owns 528 shares of the medical equipment provider’s stock worth $41,000 after buying an additional 266 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.
Integer Trading Down 1.2%
NYSE:ITGR opened at $90.97 on Friday. The company has a current ratio of 3.75, a quick ratio of 2.38 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $3.09 billion, a PE ratio of 22.68, a price-to-earnings-growth ratio of 2.17 and a beta of 0.66. The firm’s 50 day moving average is $88.44 and its 200 day moving average is $84.13. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $123.78.
Analyst Upgrades and Downgrades
Several research firms have commented on ITGR. Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, February 24th. Citigroup lifted their target price on shares of Integer from $89.00 to $92.00 and gave the stock a “neutral” rating in a research report on Thursday, May 28th. Raymond James Financial reissued an “outperform” rating and set a $101.00 target price on shares of Integer in a research report on Monday, February 23rd. Wells Fargo & Company lifted their target price on shares of Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, February 20th. Finally, Truist Financial lifted their target price on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th. Four analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $98.71.
View Our Latest Stock Analysis on ITGR
Integer Profile
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Featured Articles
- Five stocks we like better than Integer
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
